BRENDA KOZAK: Open Payments
NPI 1104378744 · MADISON HEIGHTS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$512 in 13 payments from 10 companies in 2025. Trend: 2023 $1,388 · 2024 $1,360 · 2025 $512
Food & beverage: $512
| Company | Payments | Amount |
|---|---|---|
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 1 | $111 |
| Merck Sharp & Dohme LLC | 1 | $110 |
| ABBVIE INC. | 2 | $104 |
| E.R. Squibb & Sons, L.L.C. | 2 | $48 |
| Dexcom, Inc. | 2 | $37 |
| Novo Nordisk Inc | 1 | $22 |
| Abbott Laboratories | 1 | $22 |
| Lilly USA, LLC | 1 | $20 |
| SANOFI PASTEUR INC. | 1 | $18 |
| Alkermes, Inc. | 1 | $18 |
Products named: CAPLYTA, CAPVAXIVE, QULIPTA, COBENFY, Dexcom G6 Transmitter, Ozempic, FREESTYLE LIBRE 3, MOUNJARO.
Industry payments across VA — which companies pay providers there.
